GlassScriptPhysician profile
Bryon Evan Rubery
NPI 1447297833
$8,634.33
in general payments reported to CMS, 2019-2025
25 companies · $836 in 2025
The $836 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,315 · 2020: $1,315 · 2021: $1,546 · 2022: $1,734 · 2023: $1,260 · 2024: $628 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,724.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,849.52 | 2019-2025 | Watchman Access System, Farapulse, Rhythmia Mapping System |
| Novartis Pharmaceuticals Corporation | $1,081.63 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $558.33 | 2019-2025 | Lokelma, Wainua |
| Cardiva Medical, INC. | $557.69 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Savvywire |
| E.R. Squibb & Sons, L.L.C. | $545.33 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $542.51 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $524.50 | 2019-2025 | Aveir, Assurity, Tendril |
| Medtronic, INC. | $510.72 | 2021-2025 | Pulseselect, Affera Mapping System, Linq II |
| Biosense Webster, INC. | $432.46 | 2019-2025 | Na, Smartablatetm System Rf Generator, Carto 3 |
| Janssen Pharmaceuticals, INC | $431.30 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $272.35 | 2019-2024 | Lifevest |
| Biotronik INC. | $228.72 | 2019-2024 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Biomonitor |
| Medtronic Vascular, INC. | $219.80 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.09 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $141.85 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $133.50 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Vital Connect, INC | $87.87 | 2023-2025 | Vitalpatch Rtm |
| Otsuka America Pharmaceutical, INC. | $73.06 | 2019 | |
| Pfizer INC. | $49.05 | 2019-2021 | |
| Zoll Respicardia, INC. | $37.78 | 2023 | Remede System |
| Heartflow, INC. | $34.32 | 2025 | |
| Novo Nordisk INC | $33.91 | 2023-2024 | Rybelsus, Ozempic |
| Elutia, INC. | $33.61 | 2024-2025 | Ecm Patch,Pouch |
| Siemens Medical Solutions USA, INC. | $19.99 | 2025 | Artis Pheno |
| Portola Pharmaceuticals, LLC | $15.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryon Rubery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.